Don Ma is an anchor and senior business correspondent based at the network's global headquarters in New York City. Don is the anchor and producer of NTD's "Business Matters," which airs weekdays at 4:30 pm ET.

Don Ma

NTD Plus

News

Breaking news and in-depth analysis from the United States and beyond. We bring you the latest updates, exclusive insights, and sharp discussions on the most pressing issues. NTD Newsroom airs Monday–Friday from 2 p.m. to 6 p.m. ET.

NTD Newsroom

We Need to Strengthen Our Patent System to Prevent Chinese IP Theft: Inventor

‘The Chinese Communist Party Is an Existential Enemy of the United States’: China Analyst

Economist Expects US Dollar ‘to Strengthen’ After US–China Talks

Arleen Richards is NTD's legal correspondent based at the network's global headquarters in New York City, where she covers all major legal stories. Arleen holds a Doctor of Law (J.D.).


Arleen Richards

Global Celebrations for World Falun Dafa Day Represent ‘Being True, Good and Enduring’: Jan Jekielek

Man Who Visited Every Country Shares Tips on How to Travel With Purpose

China Is ‘Helping Iranian Regime Kill Americans’: Former CIA Operations Officer

Economic Pressure In Hormuz Strait A 'Checkmate Move' From US: Foreign Relations Analyst

Sherry Ning is a reporter based at NTD's global headquarters in New York City, where she covers local news.

Sherry Ning

21-Year-Old Falun Dafa Practitioner Shares Story of Parents' Persecution in China

‘It’s an Important Week’ to Honor ‘Courage and Sacrifice’ of Law Enforcement: Former Officer

‘Opening the Strait of Hormuz by Military Means Is Not Far Off’: National Security Expert

NTD Newsroom Full Broadcast (May 15)

NTD Newsroom Full Broadcast (May 14)

NTD Newsroom Full Broadcast (May 13)

NTD Newsroom Full Broadcast (May 12)

NTD Newsroom Full Broadcast (May 11)

NTD Newsroom Full Broadcast (May 8)

NTD Newsroom Full Broadcast (May 7)

NTD Newsroom Full Broadcast (May 6)

NTD Newsroom Full Broadcast (May 5)

NTD Newsroom Full Broadcast (May 4)

NTD Newsroom comprises teams of reporters, editors, and producers assigned to cover breaking news and other stories.


Fast, compelling, first-hand news from China. China in Focus airs Monday–Friday at 8 p.m. ET.

China in Focus

China Sends Warships to Pacific Drill as Tensions With Japan Rise

Reuters is a news agency owned by Thomson Reuters. It employs around 2,500 journalists and 600 photojournalists in about 200 locations worldwide writing in 16 languages.

Reuters

We present news that is truthful and based on facts, outside of the political fog. Instead of focusing on the negative things happening around us, our mission is to give our viewers a good morning with empathetic and uplifting stories. Our aim is to provide an antidote to negativity by shining a light on the best side of people. We speak to inspiring people who positively impact communities, pursue topics that represent our common human values, and will never miss an opportunity to bring you heartwarming stories.

NTD Good Morning

2 US Embassy Personnel Assigned to Cartel Case Killed in Car Accident

The Associated Press is an American not-for-profit news agency headquartered in New York City. 

The Associated Press

US News

Gunman Kills 8 Children, Including 7 of His Own, in Louisiana Mass Shooting

Flora Hua is a reporter based at NTD's global headquarters in New York City, where she covers China news, U.S.-China relations, and human rights issues. Flora primarily contributes to NTD's "China in Focus."  

Flora Hua

Trump: Seized Iranian Ship May Have ‘A Gift From China’

Joseph Lord is a congressional reporter for The Epoch Times.


Joseph Lord

Aldgra Fredly is a freelance writer covering U.S. and Asia Pacific news for The Epoch Times.

Aldgra Fredly

Former NYC Mayor Rudy Giuliani Hospitalized in Critical Condition: Spokesman

Wildfires Across Georgia and Florida Have Destroyed Nearly 50 Homes and Are Forcing Evacuations

News you can trust from the U.S. and around the world. Critical information and insight. We cover the stories that others don’t. NTD News Today airs Monday–Friday at 11 a.m. ET.

NTD News Today

US Warns of China Hacks via Routers, Smart Devices

Juliet Song is an international correspondent exclusively covering China news for NTD. She primarily contributes to NTD's "China in Focus," covering U.S.-China relations, the Chinese regime's human rights abuses, and domestic unrest inside China.

Juliet Song

2 Americans Among Suspected Communist Rebels Killed in Clashes With Troops, Philippine Officials Say

Ryan Morgan is a reporter for The Epoch Times focusing on military and foreign affairs. He was previously a news writer for NTD. 


Ryan Morgan

Mari Otsu is NTD's White House correspondent based in Washington. 

Mari Otsu

World News

Middle East

Iran

3 US Warships Fend Off Iranian Attacks, Trump Says Ceasefire Still Holds

Health News

3 Dead in Suspected Hantavirus Outbreak on Cruise Ship in Atlantic Ocean: WHO

Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at zack.stieber@epochtimes.com

Zachary Stieber

Health officials announced on Oct. 29 that they are proposing the elimination of testing requirements for biosimilars, or generic versions of biologic drugs.

The Food and Drug Administration in <a href="https://www.fda.gov/media/189366/download">draft guidance</a> said it will reduce instances where large human trials are required for biosimilars.

If a comparative analytical assessment shows that a biosimilar is similar to a biologic, then a comparative efficacy study “may not be necessary,” the guidance states.

“We’re cutting unnecessary red tape, reducing uncertainty, and making it easier for innovators to bring safe, affordable biosimilars to the market,” Health Secretary Robert F. Kennedy Jr., whose Department of Health and Human Services includes the FDA, said at a news conference in Washington.

Biologics include medications for cancer and autoimmune disorders. They comprise 5 percent of the prescriptions in the United States, but as of 2024 accounted for 51 percent of drug spending, the FDA said. Some of the spending came from the government-funded Medicare and Medicaid programs.

Biosimilars typically cost less than similar biologic drugs, and help drive down the cost of the biologics, according to officials.

Under existing regulations, which Kennedy and FDA Commissioner Dr. Marty Makary said were outdated and too cumbersome, it takes five to eight years to bring biosimilars to market.

The updated guidance will cut that time in half and save companies $100 million in costs, said Makary, citing discussions with unspecified companies.

“Lowered prices for drug development means lower R&D costs and lower prices for everyday Americans,” he told the briefing.

Congress laid out the approval pathway for biosimilars in a 2010 law called the Biologics Price Competition and Innovation Act.

The FDA has <a href="https://www.fda.gov/drugs/biosimilars/biosimilar-product-information">approved</a> 76 biosimilars, including several generic versions of Actemra, a drug prescribed for rheumatoid arthritis and other conditions. In 2024, it approved 41. That year, the European Medical Agency approved 110.

Makary said the FDA should have approved 200 or 300 biosimilars by now.

The Association for Accessible Medicines’ Biosimilars Council, which says it works to increase access to biosimilars, and the Pharmaceutical Research and Manufacturers of America, which represents drug manufacturers such as Bristol Myers Squibb and Pfizer, did not respond to requests for comment.

The FDA is also for most biosimilars removing the recommendation that they are tested in switching studies, or testing of the biosimilars against brand-name biologics.

That will enable pharmacists to help patients choose the more affordable option, officials said. Pharmacists can currently substitute generic drugs for brand-name drugs.

<em>From<a href="https://www.theepochtimes.com/us/fda-says-its-eliminating-requirements-for-generic-versions-of-expensive-drugs-5936709"> The Epoch Times</a></em>

Latest

Paywall Related

Videos

04_Top Stories

Latest Clips

Free for Subscribers

Management

03_Featured

Latest and breaking news, documentaries, movies, and lifestyle content on NTD+.
 
Empower your knowledge and elevate your spirit with NTD+, your go-to destination for truthful news, insightful documentaries, and captivating lifestyle content that enriches your life.

FDA Says It’s Eliminating Requirements for Generic Versions of Expensive Drugs

Trump Should Raise Human Rights Issues at Xi Meeting: Entrepreneur and Friend of Jimmy Lai

Trump, US Must Guard Against Chinese Regime’s Infiltration of South Korea: Former US Ambassador

Andrew Moran has been writing about business, economics, and finance for more than a decade. He is the author of "The War on Cash."

Andrew Moran

Fed Cuts Rates by Quarter Point

Guy Birchall is a UK-based journalist covering a wide range of national stories with a particular interest in freedom of expression and social issues.

Guy Birchall

Arian Pasdar is an international correspondent for NTD News based in South America. His reporting focuses on immigration and key events in Latin America.

Arian Pasdar

Russia Tests Nuclear-Capable Poseidon Super Torpedo

NTD Newsroom Full Broadcast (Oct. 29)

Panel: Will Fallout From Food Stamps and Flight Delays Turn the Shutdown Tide?

Americans Should Be Worried About Integration of AI With Political Institutions: Analyst

Sean Marshall is a reporter based at NTD's global headquarters in New York City, primarily covering business and technology trends. 